S А Boytsov
Biographic Data
| ID | 7701537 |
|---|---|
| NAME | S А Boytsov |
| GIVEN NAMES | S А |
| FAMILY NAME | Boytsov |
| SIGNATURE | BOYTSOV S А |
| AFFILIATIONS | National Research Center for Preventive Medicine |
| ORCID | 0000-0001-6998-8406 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Lipoprotein Profile in Populations from Regions of the Russian Federation
This study aimed to describe the dyslipidemia prevalence and pattern among adult populations from different regions ( n = 13) of the Russian Federation (RF). Randomly selected samples ( n = 22,258, aged 25-64) were studied according to the ESSE-RF protocol. Lipoprotein parameters were estimated by routine methods. Statistical analyses were performed using R software (v.3.5.1). The overall dyslipidemia prevalence was 76.1% (76.9/75.3% for men/wome…
Russia SimSmoke
SimSmoke results highlight the relative contribution of policies to reducing the tobacco health burden in Russia. Significant inroads to reducing smoking prevalence and premature mortality can be achieved through strengthening tobacco control policies in line with FCTC recommendations
No prominent works on this page.
Russia SimSmoke
SimSmoke results highlight the relative contribution of policies to reducing the tobacco health burden in Russia. Significant inroads to reducing smoking prevalence and premature mortality can be achieved through strengthening tobacco control policies in line with FCTC recommendations
Lipoprotein Profile in Populations from Regions of the Russian Federation
This study aimed to describe the dyslipidemia prevalence and pattern among adult populations from different regions ( n = 13) of the Russian Federation (RF). Randomly selected samples ( n = 22,258, aged 25-64) were studied according to the ESSE-RF protocol. Lipoprotein parameters were estimated by routine methods. Statistical analyses were performed using R software (v.3.5.1). The overall dyslipidemia prevalence was 76.1% (76.9/75.3% for men/wome…
Demography (2 works) · Demography (2 works) · Environmental health (2 works) · Medicine (2 works) · Population (2 works) · Air Quality and Health Impacts (1 works) · Apolipoprotein B (1 works) · Cardiovascular Health and Risk Factors (1 works) · Cholesterol (1 works) · Disease (1 works)